ModernaMRNA
那斯達克 · USD
49.81
+6.81
(+15.84%)
收盤 01/22 05:00 (UTC+8)
盤後
51.45
+1.64
(+3.29%)
01/22 05:00 (UTC+8)
ModernaMRNA
49.81
+6.81
(+15.84%)
財務數據
損益表
- 3.44
- 18.31
- 28.11
- 1.67
- 2.41
- 18.62
- 9.66
- 1.08
- 1.42
- 10.16
- -81.53
- 479.43
- 57.30
- -94.06
- 44.31
- 672.61
- -48.12
- -88.82
- 31.48
- 615.49
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 1,016,000 | 142,000 | 108,000 | 966,000 | 1,862,000 | 241,000 | 167,000 | 2,811,000 | 1,831,000 | 344,000 |
營業成本 | 207,000 | 119,000 | 90,000 | 739,000 | 514,000 | 115,000 | 96,000 | 929,000 | 2,241,000 | 731,000 |
營業毛利 | 809,000 | 23,000 | 18,000 | 227,000 | 1,348,000 | 126,000 | 71,000 | 1,882,000 | -410,000 | -387,000 |
營業費用 | 1,069,000 | 930,000 | 1,068,000 | 1,473,000 | 1,418,000 | 1,489,000 | 1,337,000 | 1,876,000 | 1,602,000 | 1,480,000 |
研發費用 | 801,000 | 700,000 | 856,000 | 1,122,000 | 1,137,000 | 1,221,000 | 1,063,000 | 1,406,000 | 1,160,000 | 1,148,000 |
推銷及管理費用 | 268,000 | 230,000 | 212,000 | 351,000 | 281,000 | 268,000 | 274,000 | 470,000 | 442,000 | 332,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -260,000 | -907,000 | -1,050,000 | -1,246,000 | -70,000 | -1,363,000 | -1,266,000 | 6,000 | -2,012,000 | -1,867,000 |
其他收入及費用 | 73,000 | 89,000 | 86,000 | 62,000 | 91,000 | 84,000 | 101,000 | 64,000 | 54,000 | 118,000 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -187,000 | -818,000 | -964,000 | -1,184,000 | 21,000 | -1,279,000 | -1,165,000 | 70,000 | -1,958,000 | -1,749,000 |
所得稅 | 13,000 | 7,000 | 7,000 | -64,000 | 8,000 | - | 10,000 | -147,000 | 1,672,000 | -369,000 |
稅後純益 | -200,000 | -825,000 | -971,000 | -1,120,000 | 13,000 | -1,279,000 | -1,175,000 | 217,000 | -3,630,000 | -1,380,000 |
基本每股稅後盈餘(元) | -0.51 | -2.13 | -2.52 | -2.91 | 0.03 | -3.33 | -3.07 | 0.57 | -9.53 | -3.62 |
稀釋每股稅後盈餘(元) | -0.51 | -2.13 | -2.52 | -2.91 | 0.04 | -3.34 | -3.07 | 0.56 | -9.50 | -3.58 |
基本平均股數(千股) | 390000.00 | 388000.00 | 386000.00 | 385000.00 | 385000.00 | 384000.00 | 382000.00 | 381000.00 | 381000.00 | 381000.00 |
稀釋平均股數(千股) | 390000.00 | 388000.00 | 386000.00 | 385000.00 | 399000.00 | 384000.00 | 382000.00 | 395000.00 | 381000.00 | 381000.00 |
還原基本每股稅後盈餘(元) | -0.51 | -2.13 | -2.52 | -2.91 | 0.03 | -3.33 | -3.07 | 0.57 | -9.53 | -3.62 |
還原稀釋每股稅後盈餘(元) | -0.51 | -2.13 | -2.52 | -2.91 | 0.04 | -3.34 | -3.07 | 0.56 | -9.50 | -3.58 |
還原基本平均股數(千股) | 390,000 | 388,000 | 386,000 | 385,000 | 385,000 | 384,000 | 382,000 | 381,000 | 381,000 | 381,000 |
還原稀釋平均股數(千股) | 390,000 | 388,000 | 386,000 | 385,000 | 399,000 | 384,000 | 382,000 | 395,000 | 381,000 | 381,000 |
EBITDA(千元) | -152,000 | -779,000 | -944,000 | -1,143,000 | 52,000 | -1,266,000 | -1,156,000 | 252,000 | -1,721,000 | -1,669,000 |